ETS2, one of the members of the ETS family as ERG, was previously characterized as a proto-oncogene in AMKL children that is Down-syndrome and non-Down-syndrome-related [10], but the expression and clinical prognosis of ETS2 in AML remains unknown. This evidence concerns the gene ERG and acute megakaryoblastic leukemia.